CONCORD HC GP (02453.HK) -0.130 (-8.725%) announced that it proposed to issue convertible bonds in the principal amount of HKD68 million to a wholly-owned subsidiary of CSPC PHARMA (01093.HK) -0.060 (-0.740%) Short selling $90.59M; Ratio 14.677% . The aggregate net proceeds from the issue of the Bonds, after deduction of fees, commissions and other related expenses, are estimated to be approximately HK$63.1 million. The price at which Conversion Shares will be issued upon conversion will initially be HK$1.7 per Conversion Share. The company intends to use approximately 70% of the net proceeds to repay loans provided by financial institutions to the Company and its subsidiaries, including but not limited to principal and interest of working capital loans, principal and interest of fixed asset loans, and financial leasing liabilities, which is expected to be fully utilized by 31 December 2026; and approximately 30% will be used to supplement working capital of the Company and its subsidiaries for general corporate purposes, which is expected to be fully utilized by 31 December 2026.Related NewsCiti: Fundamentals of China Healthcare Sector Continue to Improve; Top Picks WUXI APPTEC (02359.HK), WUXI BIO (02269.HK), ALI HEALTH (00241.HK)The bonds will be convertible into 40 million H shares, representing approximately 4.86% of the enlarged total number of issued shares. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)
AASTOCKS Financial News